determin
inhibitori
effect
gl
hiv
replic
mdm
cell
expos
per
ml
hiv
pmn
cell
syngen
mdm
presenc
gl
viral
replic
shown
cultur
mdm
expos
per
ml
hiv
wherea
hiv
shown
replic
mdm
pmn
viral
replic
mdm
pmn
shown
cultur
perform
gl
figur
next
experi
mdm
expos
per
ml
hiv
pmn
compar
control
growth
hiv
mdm
viral
replic
mdm
pmn
enhanc
eightfold
figur
time
viral
replic
complet
inhibit
gl
mdm
pmn
figur
inhibitori
effect
gl
mdm
expos
per
ml
hiv
healthi
pmn
examin
shown
figur
signific
inhibit
viral
replic
shown
gl
dose
rang
ad
cultur
figur
inhibit
indic
cultur
perform
gl
next
inhibitori
effect
gl
hiv
replic
mdm
transwel
cultur
pmn
examin
mdm
lower
chamber
expos
per
ml
hiv
cultur
pmn
cell
upper
chamber
doubl
chamber
transwel
supplement
gl
h
cultiv
upper
chamber
remov
mdm
lower
chamber
cultur
addit
day
cultur
fluid
harvest
assay
antigen
result
pg
antigen
detect
cultur
fluid
mdm
wherea
pg
antigen
decreas
detect
cultur
supplement
gl
figur
polymorphonuclear
neutrophil
influenc
hiv
produc
wherea
factor
produc
healthi
donor
pmn
therefor
effect
gl
product
pmn
previous
expos
hiv
examin
thu
pmn
cell
stimul
per
ml
hiv
h
wash
media
cultur
gl
addit
h
cultur
fluid
harvest
assay
elisa
result
ng
pg
detect
cultur
fluid
pmn
viru
howev
product
pmn
expos
viru
greatli
decreas
reduct
cultur
perform
gl
figur
presenc
mixtur
effect
gl
hiv
replic
mdm
examin
replic
hiv
cultur
mdm
greatli
increas
mixtur
ng
ng
ad
cultur
cultur
howev
viral
replic
suppress
gl
figur
result
indic
hiv
replic
enhanc
mixtur
influenc
gl
earlier
studi
gl
shown
inhibitori
replic
hiv
pbmc
patient
hiv
infect
mdm
expos
hiv
studi
activ
gl
display
induct
product
one
cellular
entri
site
hiv
surfac
target
cell
block
chemokin
addit
hiv
activ
gl
shown
monocyt
previous
treat
express
monocyt
stimul
releas
monocyt
treat
howev
presenc
gl
produc
monocyt
treat
paper
inhibitori
effect
gl
hiv
replic
mdm
pmn
examin
replic
hiv
mdm
greatli
enhanc
cell
expos
viru
pmn
enhanc
replic
mdm
pmn
inhibit
gl
inhibit
viral
replic
shown
gl
dose
ad
inhibit
shown
gl
ad
properti
gl
report
mani
paper
gl
concentr
rang
cytotox
variou
murin
human
tissu
cultur
cell
addit
test
toxic
gl
human
pmn
trypan
blue
test
pmn
shown
viabl
cultiv
healthi
donor
peripher
blood
pmn
cell
h
medium
supplement
fetal
bovin
serum
gl
microscop
examin
morpholog
chang
pmn
gl
shown
previou
descript
data
indic
cytotox
properti
gl
involv
antivir
activ
hiv
replic
mdm
pmn
antivir
mechan
gl
enhanc
replic
hiv
mdm
pmn
examin
next
solubl
factor
releas
pmn
indic
effector
molecul
enhanc
replic
hiv
mdm
viral
replic
greatli
enhanc
mdm
transwel
cultur
pmn
inde
enhanc
viral
replic
shown
mixtur
mab
direct
ad
transwel
cultur
contrast
without
pmn
replic
hiv
greatli
enhanc
mdm
cultur
supplement
mixtur
studi
replic
hiv
enhanc
mdm
pmn
transwel
cultur
supplement
gl
howev
enhanc
hiv
replic
mdm
cultur
supplement
mixtur
influenc
gl
gl
suppress
releas
pmn
influenc
hiv
result
indic
gl
suppress
enhanc
replic
hiv
mdm
transwel
cultur
pmn
inhibit
product
pmn
influenc
hiv
assay
system
mdm
previous
expos
per
ml
hiv
bottom
chamber
cultur
pmn
upper
chamber
doubl
chamber
transwel
h
possibl
transwel
cultur
pore
small
amount
hiv
could
pass
transwel
membran
lower
chamber
upper
chamber
viral
particl
pass
membran
could
stimul
pmn
induc
product
addit
describ
monocyt
function
produc
high
level
tumor
necrosi
factor
although
system
test
function
mdm
produc
possibl
mdm
expos
hiv
may
abil
produc
addit
small
number
monocyt
contamin
pmn
prepar
may
possibl
produc
pmn
prepar
util
experi
complet
pure
pure
cell
studi
clarif
role
need
system
describ
mani
paper
enhanc
replic
hiv
tissu
cultur
cell
thu
replic
hiv
patient
pbmc
deplet
cell
increas
intracellular
growth
hiv
mdm
enhanc
addit
increas
hiv
replic
cultur
monocyt
mdm
earlier
studi
hiv
grown
freshli
isol
monocyt
previous
treat
produc
monocyt
stimul
examin
mechan
hiv
stimul
product
pmn
pmn
stimul
ultraviolet
uv
hiv
correspond
viabl
hiv
signific
amount
detect
cultur
fluid
wherea
solubl
factor
produc
pmn
stimul
viabl
hiv
indic
induc
viabl
hiv
inactiv
hiv
cultur
pmn
although
peripher
blood
pmn
known
unconvent
express
endogen
bind
hiv
remain
unclear
receptor
pmn
trigger
hiv
studi
requir
recombin
human
purchas
peprotech
rocki
hill
nj
usa
mab
obtain
bd
pharmingen
san
diego
ca
usa
gl
suppli
minophagen
pharmaceut
co
ltd
tokyo
japan
accord
previou
paper
mg
gl
dissolv
ml
cultur
medium
room
temperatur
dilut
appropri
concentr
use
experi
pbmc
prepar
heparin
whole
blood
sediment
monocyt
isol
pbmc
use
plate
previous
describ
briefli
pbmc
cell
place
plate
plate
incub
min
allow
monocyt
attach
float
cell
remov
wash
warm
medium
attach
monocyt
maintain
cultur
day
medium
supplement
human
ab
serum
st
loui
mo
usa
mm
antibiot
allow
differenti
mdm
use
hiv
infect
hiv
strain
propag
healthi
donor
pbmc
stimul
pha
day
supernat
harvest
peak
viral
infect
store
previous
describ
polymorphonuclear
neutrophil
isol
whole
peripher
blood
use
dextran
sediment
thu
sediment
whole
blood
precipit
obtain
fraction
elimin
erythrocyt
precipit
suspend
dextran
kept
min
room
temperatur
result
pmn
fraction
treat
buffer
r
system
minneapoli
mn
usa
elimin
remain
erythrocyt
contamin
monocyt
lymphocyt
elimin
use
magnet
bead
coat
mab
puriti
pmn
final
obtain
analyz
stain
cell
viabil
higher
determin
trypan
blue
test
macrophag
cell
expos
hiv
per
ml
h
afterward
excess
virus
remov
wash
warm
medium
cell
pmn
cell
everi
day
cultur
fluid
harvest
amount
hiv
antigen
cultur
fluid
measur
elisa
beckman
coulter
somerset
nj
usa
macrophag
lower
chamber
expos
per
ml
hiv
cultur
pmn
cell
per
ml
upper
chamber
doubl
chamber
transwel
pore
corn
costar
ny
usa
h
cultiv
upper
chamber
remov
cell
lower
chamber
day
quantiti
antigen
cultur
fluid
mdm
determin
elisa
macrophag
expos
transwel
cultur
pmn
mention
media
supplement
gl
test
group
media
control
group
total
day
cultiv
cultur
fluid
harvest
group
amount
hiv
antigen
cultur
fluid
measur
elisa
mixtur
ng
ng
ad
mdm
treat
gl
h
hiv
infect
per
ml
quantiti
antigen
cultur
fluid
mdm
determin
elisa
polymorphonuclear
neutrophil
cell
expos
per
ml
hiv
h
cultiv
cell
wash
media
gl
h
cultiv
amount
cultur
fluid
measur
elisa
detect
limit
pg
respect
assay
perform
three
time
data
shown
figur
deriv
three
independ
experi
use
differ
donor
data
present
result
statist
analyz
anova
analysi
varianc
use
statview
brain
power
calabasa
ca
usa
lower
result
consid
signific
thank
minophagen
pharmaceut
co
ltd
tokyo
japan
gener
donat
gl
